File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

TitleAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
Authors
Issue Date2005
PublisherWiley-Blackwell Publishing, Inc. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1478-3223&site=1
Citation
Liver International, 2005, v. 25, p. 472-289 How to Cite?
AbstractBACKGROUND/AIMS: A large amount of new data on the treatment of chronic hepatitis B has become available such that the 2003 consensus statement requires revision and update. METHODS: New data were presented, discussed and debated in an expert pre-meeting to draft a revision. The revised contents were finalized after discussion in a general meeting of APASL. RESULTS: Conceptual background, including the efficacy and safety profile of currently available and emerging drugs, was reviewed. Nineteen recommendations were formed and unresolved issues and areas for further study were suggested. CONCLUSION: The current therapy of chronic hepatitis B is modestly effective but not satisfactory. The development of new drugs and new strategies is required to further improve the outcomes of treatment.
Persistent Identifierhttp://hdl.handle.net/10722/211517
ISSN
2015 Impact Factor: 4.47
2015 SCImago Journal Rankings: 1.677

 

DC FieldValueLanguage
dc.contributor.authorLiaw, YF-
dc.contributor.authorLeung, N-
dc.contributor.authorGuan, R-
dc.contributor.authorLau, GKK-
dc.contributor.authorMerican, I-
dc.contributor.authorMcCaughan, G-
dc.contributor.authorGane, E-
dc.contributor.authorKao, JH-
dc.contributor.authorOmata, M-
dc.date.accessioned2015-07-16T03:22:42Z-
dc.date.available2015-07-16T03:22:42Z-
dc.date.issued2005-
dc.identifier.citationLiver International, 2005, v. 25, p. 472-289-
dc.identifier.issn1478-3223-
dc.identifier.urihttp://hdl.handle.net/10722/211517-
dc.description.abstractBACKGROUND/AIMS: A large amount of new data on the treatment of chronic hepatitis B has become available such that the 2003 consensus statement requires revision and update. METHODS: New data were presented, discussed and debated in an expert pre-meeting to draft a revision. The revised contents were finalized after discussion in a general meeting of APASL. RESULTS: Conceptual background, including the efficacy and safety profile of currently available and emerging drugs, was reviewed. Nineteen recommendations were formed and unresolved issues and areas for further study were suggested. CONCLUSION: The current therapy of chronic hepatitis B is modestly effective but not satisfactory. The development of new drugs and new strategies is required to further improve the outcomes of treatment.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing, Inc. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1478-3223&site=1-
dc.relation.ispartofLiver International-
dc.subject.meshAntiviral Agents - therapeutic use-
dc.subject.meshAsia-
dc.subject.meshAustralia-
dc.subject.meshHepatitis B, Chronic - drug therapy-
dc.subject.meshPractice Guidelines as Topic-
dc.titleAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update-
dc.typeArticle-
dc.identifier.emailLau, GKK: gkklau@netvigator.com-
dc.identifier.doi10.1111/j.1478-3231.2005.01134.x-
dc.identifier.pmid15910483-
dc.identifier.hkuros100552-
dc.identifier.hkuros112032-
dc.identifier.volume25-
dc.identifier.spage472-
dc.identifier.epage89-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats